Published Jan 8, 2020

#79 The Anti-JUUL

Explore the innovation and investment dynamics behind Hava Health's pioneering smoking cessation vape as founder Josh Israel navigates regulatory challenges to transform nicotine addiction treatment, capturing investors' interest with a mission-driven approach.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

#37 Can Tech Solve America’s Drug Crisis?
Answers 383 questions
#112 Natrion: The Holy Grail of Battery Tech
Answers 383 questions
#74 Stop Killing Your Plants
Answers 383 questions
#66 Does Anyone Really Want Your Product?
Answers 383 questions
#109 Modern Picnic: Surviving the Adpocalypse
Answers 383 questions
#49 Nuts Can Kill. Are Seeds the Answer?
Answers 383 questions
#9 Tuckrbox
Answers 383 questions
#23 Jiobit
Answers 383 questions
#56 Shark Tank vs. The Pitch
Answers 383 questions
#31 Are Vending Machines the Future of Retail?
Answers 383 questions
#108 Qleek Pt. III: A Postmortem and a Comeback
Answers 383 questions
#97 Secret Sauce or Snake Oil?
Answers 383 questions
#143 Vital Audio
Answers 383 questions
#3 Industrial Organic
Answers 383 questions
#72 How Niche Is Too Niche?
Answers 383 questions

Dexa/The Pitch

#79 The Anti-JUUL

Topics covered

Popular Clips

Navigating FDA Challenges

Risky Investments

Post-Addiction Solutions

Navigating Vaping Scrutiny

Navigating Regulatory Challenges

Navigating Addiction Solutions

FDA Regulatory Pathway

Innovative Nicotine Solution

Investment Insights

Disrupting Smoking Cessation

Episode Highlights

Regulatory Challenges

Investment Dynamics

Innovation in Smoking Cessation

Related Episodes

#37 Can Tech Solve America’s Drug Crisis?

#112 Natrion: The Holy Grail of Battery Tech

#74 Stop Killing Your Plants

#66 Does Anyone Really Want Your Product?

#109 Modern Picnic: Surviving the Adpocalypse

#49 Nuts Can Kill. Are Seeds the Answer?

#9 Tuckrbox

#23 Jiobit

#56 Shark Tank vs. The Pitch

#31 Are Vending Machines the Future of Retail?

#108 Qleek Pt. III: A Postmortem and a Comeback

#97 Secret Sauce or Snake Oil?

#143 Vital Audio

#3 Industrial Organic

#72 How Niche Is Too Niche?

#79 The Anti-JUUL

Topics covered

Popular Clips

Episode Highlights

Regulatory ChallengesAmidst heightened scrutiny on vaping, Josh Israel of Hava Health discusses the challenges and strategies to navigate regulatory hurdles. He emphasizes the importance of FDA approval for their smoking cessation vape and explores international markets to expedite the process.

Regulatory Challenges

Investment DynamicsThe investors weigh the risks and criteria involved in supporting Hava Health, a startup navigating regulatory challenges with its smoking cessation vape. Despite the long timeline before market entry, the founder's clarity and mission-driven approach capture their interest.

Investment Dynamics

Innovation in Smoking Cessation

Related Episodes